Page last updated: 2024-09-04

gadofosveset trisodium and Cirrhosis

gadofosveset trisodium has been researched along with Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bigalke, B; Botnar, RM; Engel, LC; Gigengack, K; Girke, G; Hamm, B; Jaguszewski, M; Landmesser, U; Lauten, A; Leistner, DM; Makowski, MR; Manes, C; Schuster, A; Skurk, C; Wurster, T1
Foster, L; Haider, M; Law, C; McGregor, C; Milot, L1

Trials

1 trial(s) available for gadofosveset trisodium and Cirrhosis

ArticleYear
Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience.
    Journal of magnetic resonance imaging : JMRI, 2012, Volume: 36, Issue:3

    Topics: Contrast Media; Female; Fibrosis; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity

2012

Other Studies

1 other study(ies) available for gadofosveset trisodium and Cirrhosis

ArticleYear
Novel Approach for In Vivo Detection of Vulnerable Coronary Plaques Using Molecular 3-T CMR Imaging With an Albumin-Binding Probe.
    JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:2

    Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Albumins; Computed Tomography Angiography; Contrast Media; Coronary Angiography; Coronary Vessels; Feasibility Studies; Female; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Organometallic Compounds; Plaque, Atherosclerotic; Predictive Value of Tests; Reproducibility of Results; Tomography, Optical Coherence

2019